Victoria's experience includes serving as lead science and patent counsel in a large pharmaceutical action at a prominent litigation firm. She has practiced patent prosecution, commercial and appellate litigation, and was founding general counsel for an information technology corporation, with responsibility for patent, trademark, technology licensing, confidentiality, and intellectual property portfolio management matters. Victoria has also lived and worked in Germany, where she focused on the EU, UK, and other national Information Privacy Directives and on the Digital Millennium Copyright Act.
Victoria performed her Master's thesis research on computer assisted empirical predictions of alpha helical secondary structure in proteins at Princeton University. She researched site directed mutagenesis of protein folding chaperonins at Brigham Young University, where she completed her Ph.D. coursework. Victoria’s current practice focuses on national and international bioscience and biotechnology patent prosecution, patentability and freedom to operate analysis, and portfolio management, with emphasis on cloning, protein expression, RNA reactions and editing, research tools, diagnostics, small molecule drug design, and immunology.
Telephone: (858) 524-6090